If you have tried multiple antidepressants and none of them have worked the way you hoped, there is a question worth asking before you try another one: is the problem the medication, or is the problem that the medication was never a good match for your biology in the first place?
GeneSight genetic testing exists to answer that question.
It is a simple cheek swab that analyzes your DNA and tells your psychiatrist which medications are likely to work well for you, which ones may work poorly, and which ones carry an elevated risk of side effects based on your specific genetic profile. It does not replace clinical judgment. It informs it, with data that was not available to psychiatrists a generation ago.
At NeuPath Mind Wellness, GeneSight testing is available across all three of our South Florida locations and is one of the tools we use to build genuinely personalized treatment plans for patients who have spent too long cycling through medications that were never right for them.
The Problem GeneSight Solves
The standard approach to prescribing antidepressants has always involved a significant degree of guesswork. A psychiatrist evaluates your symptoms, considers your history, and selects a medication based on clinical guidelines and experience. If it does not work, or if the side effects are intolerable, you try another one. And another. And another.
This trial-and-error process is not a failure of psychiatry. It reflects a genuine gap in the information available. Until recently there was no reliable way to know in advance how a specific patient’s body would process a specific medication. The same dose of the same drug can produce vastly different effects in two different people, and the reason for that difference is largely genetic.
Approximately 40 percent of patients with depression do not achieve remission with their first antidepressant. Many cycle through multiple medications over months or years before finding something that works, if they find it at all. Each failed trial is not just a clinical setback. It is months of a patient’s life spent feeling worse than necessary, often with side effects layered on top of the underlying illness.
GeneSight closes that information gap.
How GeneSight Works
GeneSight is a pharmacogenomic test, meaning it analyzes the relationship between your genes and how your body responds to medications. The test is developed and processed by Myriad Genetics, one of the leading pharmacogenomics laboratories in the United States.
The process at NeuPath is simple:
Step 1: The swab. A clinician collects a DNA sample using a simple cheek swab. The process takes less than a minute and is completely painless.
Step 2: Laboratory analysis. The sample is sent to Myriad’s laboratory where your DNA is analyzed across a panel of genes relevant to psychiatric medication metabolism and response.
Step 3: The report. Within a few days your psychiatrist receives a detailed GeneSight report that categorizes each medication in the psychiatric formulary into one of three groups based on your genetic profile.
Step 4: Clinical integration. Your psychiatrist reviews the results with you and uses the findings to inform your treatment plan, whether that means adjusting your current medication, switching to a better-matched alternative, or confirming that your current approach is genetically sound.
What the GeneSight Report Shows
The GeneSight report organizes medications into three color-coded categories:
Use as directed (green). Medications in this category are predicted to be processed normally by your body based on your genetic profile. They carry no elevated genetic risk and are reasonable options from a pharmacogenomic standpoint.
Use with caution (yellow). Medications in this category may be less effective or may require dose adjustments due to how your genes affect their metabolism. Your psychiatrist may still prescribe them but will do so with the genetic data in mind.
Use with increased caution and more frequent monitoring (red). Medications in this category carry a higher genetic risk of reduced efficacy, adverse reactions, or significant metabolic interactions. This does not mean they are never appropriate, but the data suggests they warrant careful consideration and close monitoring if prescribed.
The report covers antidepressants, antipsychotics, anxiolytics, mood stabilizers, and other psychiatric medications, giving your psychiatrist a comprehensive genetic map of the entire psychiatric formulary as it applies to your specific biology.
What Genes Does GeneSight Test?
The GeneSight panel focuses primarily on two categories of genes:
Pharmacokinetic genes govern how your body processes and metabolizes medications. The most clinically significant are the cytochrome P450 enzymes, particularly CYP2D6, CYP2C19, and CYP2C9. These enzymes are responsible for breaking down a large proportion of psychiatric medications in the liver. Genetic variants in these enzymes can make you a poor metabolizer, meaning a standard dose builds up to toxic levels in your system, or an ultra-rapid metabolizer, meaning your body clears the drug so quickly it never reaches therapeutic concentration. Either extreme explains why some patients feel terrible on medications that work well for others, or why a medication seems to stop working after a period of effectiveness.
Pharmacodynamic genes influence how your brain responds to a medication once it has been absorbed. These include genes like SLC6A4, which affects serotonin transport and influences how patients respond to SSRIs, and MTHFR, which affects folate metabolism and has been associated with antidepressant response and treatment resistance.
Understanding both dimensions, how your body processes the drug and how your brain responds to it, gives your psychiatrist a significantly more complete picture than symptom history alone.
What GeneSight Can and Cannot Tell You
GeneSight is a powerful tool but it is important to understand what it does and does not do.
What it can tell you:
- Which medications your body is likely to metabolize normally, too slowly, or too quickly
- Which medications carry a higher genetic risk of side effects or reduced efficacy for you specifically
- Whether your current medication is a good genetic match or whether switching might produce better results
- Which untried medications are worth prioritizing based on your genetic profile
What it cannot tell you:
- Whether a specific medication will definitively work for you. Genetics is one factor among many that influence treatment response. Diagnosis, symptom severity, life circumstances, and other biological variables all play a role.
- The exact dose you need. Genetic data informs dosing decisions but does not replace clinical titration.
- Whether you need medication at all. GeneSight is a tool for optimizing medication selection, not a recommendation to use medication over other treatment approaches.
At NeuPath, GeneSight results are always interpreted by a psychiatrist within the full context of your clinical picture. The report is a data input, not a prescription.
GeneSight tells your psychiatrist which medications your body is likely to metabolize normally, too slowly, or too quickly, which medications carry a higher genetic risk of side effects or reduced efficacy for you specifically, and which untried medications are worth prioritizing based on your genetic profile.
GeneSight cannot tell you whether a specific medication will definitively work for you, the exact dose you need, or whether you need medication at all. Genetics is one factor among many that influence treatment response. GeneSight results are always interpreted by a psychiatrist within the full context of your clinical picture.
GeneSight is developed and processed by Myriad Genetics, one of the leading pharmacogenomics laboratories in the United States. The test analyzes clinically validated genes with well-established relationships to psychiatric medication metabolism and response. It is not a guarantee of outcomes but it is a significant improvement over the trial-and-error approach to medication selection.
The cheek swab itself takes less than a minute. Laboratory analysis typically returns results within a few days, after which your psychiatrist reviews the report with you and integrates the findings into your treatment plan.
Who Benefits Most From GeneSight Testing?
GeneSight is valuable for a wide range of patients, but it tends to produce the most meaningful clinical impact for those in the following situations:
Patients who have tried multiple antidepressants without success. If two or more medications have failed to produce adequate relief, pharmacogenomic testing can reveal whether genetic factors are contributing to that pattern and identify better-matched alternatives.
Patients experiencing significant side effects. Intolerable side effects are often a sign of a poor pharmacokinetic match. GeneSight can explain why a medication is causing an adverse reaction and identify alternatives that are less likely to do the same.
Patients starting psychiatric medication for the first time. Rather than beginning the trial-and-error process from scratch, GeneSight gives your psychiatrist a data-informed starting point, reducing the number of failed trials before finding an effective medication.
Patients on multiple psychiatric medications. Polypharmacy introduces complex drug-drug interactions, many of which are mediated by the same cytochrome P450 enzymes GeneSight tests. The report can identify genetic risk factors for interactions that might not be apparent from a standard medication review.
Patients considering advanced treatments like TMS or ketamine. For patients who are exploring TMS, Spravato, or ketamine therapy at NeuPath, GeneSight testing helps ensure that the medication component of their care is optimized alongside the advanced treatment. A patient receiving TMS who is also on a poorly matched antidepressant may have a suboptimal response to both.
Is GeneSight Covered by Insurance?
GeneSight testing is covered by many insurance plans, including Medicare, for patients who meet clinical criteria. Coverage is most reliably established for patients with a diagnosis of depression or another psychiatric condition and a documented history of medication trials.
Our team at NeuPath handles insurance verification for GeneSight the same way we do for TMS and Spravato. We confirm your coverage before the test is ordered so you know what to expect before any cost is incurred. For patients whose insurance does not cover the test, Myriad Genetics offers a patient assistance program that significantly reduces or eliminates out-of-pocket costs for eligible patients.
GeneSight is covered by many insurance plans including Medicare for patients who meet clinical criteria. Coverage is most reliably established for patients with a diagnosis of depression or another psychiatric condition and a documented history of medication trials. NeuPath verifies your coverage before the test is ordered.
Myriad Genetics offers a patient assistance program that significantly reduces or eliminates out-of-pocket costs for eligible patients. Our team will walk you through the options before any cost is incurred.
GeneSight testing is available at NeuPath Mind Wellness across all three of our South Florida locations in Delray Beach, Boca Raton, and Boynton Beach.
No. You can book a consultation directly with our team and we will determine whether GeneSight testing is appropriate for your situation and handle the process from there.
| GeneSight at NeuPath Mind Wellness At NeuPath, GeneSight testing is not offered in isolation. It is integrated into a broader psychiatric care model that includes medication management, TMS therapy, ketamine infusions, Spravato, and ongoing psychiatric support. The goal is not just to find a medication that your genes suggest might work. It is to build a comprehensive treatment plan that addresses your depression from every relevant angle. If you have been cycling through antidepressants without finding real relief, or if you are starting psychiatric treatment for the first time and want to approach it more strategically, GeneSight testing is a logical and accessible first step. Book a consultation at NeuPath Mind Wellness in Delray Beach, Boca Raton, or Boynton Beach to discuss whether GeneSight testing is right for you. |
